CHU de Rangueil — Toulouse

Public research footprint of CHU de Rangueil, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Myocardial Infarction · Acromegaly · Hormono-depending Adjuvant Breast Cancer · Digestive System Diseases

Recently updated registry entries

NCT01127295 — Pharmacology of Adjuvant Hormonotherapy in Breast Cancer (Completed)
NCT01435291 — AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation (Completed)
NCT06904170 — Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Rangueil?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.